Essentials of Medical Pharmacology with One Stop Resource for All Your Exam Needs In Pharmacology
Key Features
- Thoroughly updated chapters, incorporating new therapeutic approaches and recently marketed drugs, such as long acting GLP-1 receptor agonists (Semaglutide) and SGLT-2 inhibitors (Dapagliflozin) for diabetes, neprilysin inhibitor (sacubitril) and SGLT-2 inhibitors for CHF, Orexin antagonists (Suvorexant) as hypnotic, Rho-kinase inhibitor (Netarsudil) for glaucoma, adrenergic beta-3 agonist (Mirabegron) for overactive bladder, PCSK9 inhibitor (lnclisiran) as long acting hypocholesterolemic, CGRP receptor antagonists (Rimegepant) for migraine, PDE-4 inhibitor (Roflumilast) for COPD, and many others.
- Latest therapeutic and prophylactic regimens recommended under the National Health Programs for MDR/XDR-tuberculosis, leprosy, HIV, malaria, kala-azar, filariasis, viral hepatitis, etc.
- Drugs and vaccines for COVID-19 and the latest AIIMS/ICMR guidelines for management of COVID.
- Pharmacovigilance program of India.
- Evidence-based medicine with authenticated reference to latest therapeutic guidelines from WHO; ACC/AHA; ISH; NICE; SIGN; Cochrane reviews, meta analysis and landmark clinical trials.
- The WHO classification of antibiotics into "AWaRe" (Access, Watch, Reserve) groups.
- A separate chapter on alcohols, drug dependence and drugs of abuse.
- A new chapter on environmental toxicology, poisonings; snake/dog bites and scorpion/bee stings.
- Chapterwise listing of abbreviations for user convenience.
- Several new figures, flowcharts, tables and highlight boxes.
- Full coverage of competency-based pharmacology curriculum of NMC for graduate medical students.
- Complementary question booklet containing theory questions-long and short answers, reasoning type, case scenario based questions, 1,200+ MCQs (including clinical and reasoning type) and OSPEs aligned with NMC recommended theory exam pattern.
Provides Additional Online/Digital Content
Dr Wise
Key Features
- Thoroughly updated chapters, incorporating new therapeutic approaches and recently marketed drugs, such as long acting GLP-1 receptor agonists (Semaglutide) and SGLT-2 inhibitors (Dapagliflozin) for diabetes, neprilysin inhibitor (sacubitril) and SGLT-2 inhibitors for CHF, Orexin antagonists (Suvorexant) as hypnotic, Rho-kinase inhibitor (Netarsudil) for glaucoma, adrenergic beta-3 agonist (Mirabegron) for overactive bladder, PCSK9 inhibitor (lnclisiran) as long acting hypocholesterolemic, CGRP receptor antagonists (Rimegepant) for migraine, PDE-4 inhibitor (Roflumilast) for COPD, and many others.
- Latest therapeutic and prophylactic regimens recommended under the National Health Programs for MDR/XDR-tuberculosis, leprosy, HIV, malaria, kala-azar, filariasis, viral hepatitis, etc.
- Drugs and vaccines for COVID-19 and the latest AIIMS/ICMR guidelines for management of COVID.
- Pharmacovigilance program of India.
- Evidence-based medicine with authenticated reference to latest therapeutic guidelines from WHO; ACC/AHA; ISH; NICE; SIGN; Cochrane reviews, meta analysis and landmark clinical trials.
- The WHO classification of antibiotics into "AWaRe" (Access, Watch, Reserve) groups.
- A separate chapter on alcohols, drug dependence and drugs of abuse.
- A new chapter on environmental toxicology, poisonings; snake/dog bites and scorpion/bee stings.
- Chapterwise listing of abbreviations for user convenience.
- Several new figures, flowcharts, tables and highlight boxes.
- Full coverage of competency-based pharmacology curriculum of NMC for graduate medical students.
- Complementary question booklet containing theory questions-long and short answers, reasoning type, case scenario based questions, 1,200+ MCQs (including clinical and reasoning type) and OSPEs aligned with NMC recommended theory exam pattern.
Provides Additional Online/Digital Content
Dr Wise
Description
The 9th Edition (Revised Reprint) of Essentials of Pharmacology presents thoroughly updated chapters incorporating new therapeutic advances and recently approved drugs, including Semaglutide, Dapagliflozin, Sacubitril, Suvorexant, Netarsudil, Mirabegron, Inclisiran, and Rimegepant, among others. It covers the latest treatment and prophylaxis guidelines under the National Health Programs and includes updated COVID-19 drugs, vaccines, and ICMR/AIIMS management protocols. The edition emphasizes evidence-based medicine with references from WHO, ACC/AHA, NICE, SIGN, and Cochrane reviews, and includes the WHO AWaRe antibiotic classification. New chapters on drug dependence, environmental toxicology, and poisonings enhance clinical relevance. A complementary question booklet with over 1,200 MCQs, reasoning, case-based, and OSPE questions aligned with the NMC curriculum makes this edition a complete learning and exam-preparation package for medical students.
Product Details
Publisher :
JPB
Online Resources :
Complimentary online Drug Atlas & MCQs
Edition :
9/e Revised Reprint
Binding :
Paper Back
Language :
English
Pages :
1324
ISBN-13 :
9789356962026
Item Weight :
2060 grams
Dimensions :
6.75 x 9.5
Printing Format Color :
Four Color
Copyright year :
2026
Chat Bot :
Dr.Wise AI Chatbot available